All influenza viruses of the type A, including those causing seasonal epidemics of human influenza

According to a news posted on Sept 28, 2005, government scientists at the US National Institute of Allergy and Infectious Diseases (NIAID) announced results from initial clinical trials of a vaccine being developed to protect humans against infection with H5N1 avian influenza. NIAID and MedImmune have joined forces to develop potential pandemic influenza vaccines. HHS Secretary Mike Leavitt today announced that NIAID and MedImmune Inc. have signed a cooperative research and development agreement for the development of vaccines against avian influenza viruses that have the potential to cause pandemics. Speaking of pandemic flu as an urgent health challenge, HHS
Secretary Mike Leavitt said. “This agreement will help speed the process of developing vaccines we will need to fight an outbreak if the avian flu starts to spread rapidly through the human population.” As per the agreement, scientists will add selected genes from avian flu viruses with pandemic potential into a weakened human flu virus to create several attenuated, live virus vaccines candidates.
Although there has been an incredible and alarming rise in human cases of bird flu, causing increasing fear of a global pandemic, there seems to be a strong resolve in the scientific community to combat this impending and much dreaded pandemic.